ELEX BIOTECH, LLC
Biotech · Private
Novel small-molecule compounds targeting RyR2 calcium release channel for catecholaminergic polymorphic ventricular tachycardia (CPVT) treatment
- Grants
- $4.9M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | $750,385 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of novel compounds for the treatment of atrial fibrillation | $427,638 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | $749,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | $999,103 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | $966,380 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | $971,323 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1136 | REGENOSINE INC | — | — |
| 1137 | Synata Bio, Inc. | — | $52M |
| 1138 | SYNSORYBIO, INC. | — | — |
| 1139 | ELEX BIOTECH, LLC | — | — |
| 1140 | NITRO BIOSCIENCES INC. | — | — |
| 1141 | PROTON BIO, INC. | — | — |
| 1142 | REZIGENE, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compounds For Treatment Of Cardiac Arrhythmiasapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.